New GERD drug shows promise in Head-to-Head trial
NCT ID NCT07326904
First seen Jan 11, 2026 · Last updated Jun 16, 2026 · Updated 24 times
Summary
This study tested whether fexuprazan, a new medication, can relieve heartburn and acid reflux symptoms in adults with GERD as well as the standard drug esomeprazole. 145 participants took either fexuprazan or esomeprazole daily for 4 to 8 weeks. The study measured symptom relief using a questionnaire and monitored safety.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GASTRO OESOPHAGEAL REFLUX DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Islam Cempaka Putih Jakarta Hospital
Jakarta Pusat, DKI Jakarta, 10510, Indonesia
-
Menteng Mitra Afia Jakarta Hospital
Jakarta Pusat, DKI Jakarta, 10340, Indonesia
-
University of Indonesia Hospital
Depok, West Java, 16424, Indonesia
Conditions
Explore the condition pages connected to this study.